Horie M, Broxmeyer H E
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202-5121.
Exp Hematol. 1995 Feb;23(2):168-73.
The effects of hematopoietic growth factors were examined on the cellular action of retinoic acid (RA) using the human factor-dependent cell line, MO7e. Treatment of cells with Steel factor (SLF) plus granulocyte-macrophage colony-stimulating factor (GM-CSF) synergistically stimulated cell proliferation compared to that with each factor alone. This synergism was even greater in the presence of RA than in its absence. Treatment of cells with RA resulted in apoptotic cell death associated with internucleosomal DNA fragmentation in the presence of either SLF or GM-CSF. RA-induced apoptosis and DNA fragmentation were completely blocked by treating cells with SLF plus GM-CSF. Northern analysis showed that the inhibition of RA effects on MO7e cells by SLF plus GM-CSF treatment occurred without modulation of expression of RA receptor-alpha (RAR-alpha) gene. Furthermore, a higher amount of AP-1 complex was detected by electrophoretic mobility shift assays in a nuclear extract prepared from cells treated with SLF plus GM-CSF compared to those treated with each factor alone, while the level of RAR-complex remained similar in cells treated with SLF and/or GM-CSF. These data suggest an interaction in signaling pathways among different types of receptors that might be associated with the AP-1 complex.
利用人因子依赖细胞系MO7e,研究了造血生长因子对维甲酸(RA)细胞作用的影响。与单独使用每种因子相比,用Steel因子(SLF)加粒细胞-巨噬细胞集落刺激因子(GM-CSF)处理细胞可协同刺激细胞增殖。在存在RA的情况下,这种协同作用比不存在时更大。在存在SLF或GM-CSF的情况下,用RA处理细胞会导致与核小体间DNA片段化相关的凋亡性细胞死亡。用SLF加GM-CSF处理细胞可完全阻断RA诱导的凋亡和DNA片段化。Northern分析表明,SLF加GM-CSF处理对MO7e细胞RA作用的抑制发生在未调节RA受体-α(RAR-α)基因表达的情况下。此外,与单独用每种因子处理的细胞相比,在用SLF加GM-CSF处理的细胞制备的核提取物中,通过电泳迁移率变动分析检测到更高量的AP-1复合物,而在用SLF和/或GM-CSF处理的细胞中,RAR复合物的水平保持相似。这些数据表明不同类型受体的信号通路之间存在相互作用,这可能与AP-1复合物有关。